Exicure (XCUR) Stock: Buy, Sell, or Hold?
XCUR - Exicure, Inc. Common Stock
$1.24
0.02 (1.23%)
â˛
5d:
-1.98%
30d:
-12.41%
90d:
-43.86%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 06, 2026
Get Alerted When XCUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: XCUR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: XCUR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: XCUR is currently trading at $1.24, which is considered slightly low relative to its 30-day fair value range of $1.21 to $1.37.
Technical Outlook: Technically, XCUR is in a strong downtrend. Immediate support is located at $1.17, while resistance sits at $1.42.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+61.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XCUR is in a strong downtrend. Immediate support is located at $1.17, while resistance sits at $1.42.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+61.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.21 -
$1.37
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.9% below Wall St target ($2.00)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.21 -
$1.37
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.17
Resistance Level
$1.42
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Wall Street Target
$2.00
(+61.9%)
Revenue Growth (YoY)
928.0%
Share & Embed Analysis
Last updated: September 29, 2026 7:45 AM ET
Data refreshes hourly during market hours. Next update: 8:45 AM
Data refreshes hourly during market hours. Next update: 8:45 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XCUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 72 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 58 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 64 BUY |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
13 analysts |
$107 | 64 BUY |